A budget impact analysis of bezlotoxumab versus standard of care antibiotics only in patients at high risk of CDI recurrence from a hospital management perspective in Germany

by Florian Jakobs, Sebastian Marcel Wingen-Heimann, Julia Jeck, Anna Kron, Oliver Andreas Cornely, Florian Kron
Published 2021-09-01